Zhejiang Lepu Pharmaceutical Co.,Ltd. (formerly known as Zhejiang Neo-dankong Pharmaceutical Co.,Ltd.), founded in 2001, is now located in Jiaojiang Chemical API Industrial Park, Taizhou City, Zhejiang Province. With an area of 152,000 square meters, Zhejiang Lepu is mainly engaged in the R&D, production and sales of medicines for Cardiovascular, Anti-Infectives, Oncology, Nervous System and other categories. In 2014, Lepu Medical Technology (Beijing) Co., Ltd. was introduced into the management then becoming the controlling shareholder, serving as the main pharmaceutical manufacturer/company of the comprehensive cardiovascular health platform combining with Medical Devices, Pharmaceutical, Healthcare Services and Mobile Medical. The main products of Zhejiang Lepu include Atorvastatin Calcium, Norfloxacin, Rosuvastatin Calcium, Sertraline HCl and other APIs and preparations. Zhejiang Lepu has a solid GMP system, with certifications including CFDA for China, FDA for USA , MHRA for UK, COS for EU, PMDA for Japan, KFDA for South Korea, etc. Many product categories are taking the leading positions in the world.
Zhejiang Lepu is a state-level high-tech enterprise and provincial-level patent demonstration enterprise, with state-level academician workstation and a provincial-level research institute. The company has established joint laboratories with renowned universities and research institutes, including Nankai University, Zhejiang University of Technology, China State Institute of Pharmaceutical Industry. Zhejiang Lepu also hired a group of professors and industrial specialists as the research and development experts to better power the research engine of the company. In recent years, Zhejiang Lepu has strengthened the efforts in the R&D of new products and the protection of intellectual property rights with more than 25 patents obtained. Zhejiang Lepu has extensive cooperation with more than 20 international pharmaceutical companies, speeding up the R&D of cardiovascular, oncology and other new drugs which provides sustainable power for medium and long-term development for the company.
In the future, Zhejiang Lepu will be adhering to the core values of “honesty, innovation, integrity, win-win” and the enterprise spirit of “Dedication, Law-abiding, Contribution”, working diligently to be explorative and innovative. We will continue to enhance our core strength through innovation, upgrading of product pipeline, extension of industrial value chain, improvement of equipment and techniques, to excel in the production of API and finished dosage forms, striving to become a modern pharmaceutical enterprise with international competitiveness.